United States
Sanofi Commits $20 Billion to U.S. R&D and Manufacturing by 2030
Sanofi; $20 billion investment; U.S. manufacturing; R&D; job creation; drug launches; domestic partnerships
Roche injects $550M into Indianapolis hub to scale up CGM production
Indianapolis, Roche (company), Continuous glucose monitoring, production, Manufacture, Investments, United States
Roche could rethink $50B US expansion plan if new policies ‘harm’ operations
Roche (company), United States, Investments, expansion, Policy, Infantile Neuroaxonal Dystrophy
Trump signs sweeping executive order to cut US drug prices by ‘up to 90%’
Prices, HHS, United States, Transplant Registry Unified Management Program, Policy
Gilead tees up $11B in new US manufacturing, R&D investments
United States, Investments, Manufacture, R&D, Billion, U.S.
Amid Trumps Trade War, Some Drugmakers Stockpile Products in U.S.
United States, Import, trade deficit
Trump, FDA zero in on foreign factories to give domestic sites an edge
United States Food and Drug Administration, United States, Transplant Registry Unified Management Program, foreign factories, manufacturers
Pfizer’s Bourla is ‘cautiously optimistic’ on tariffs, says M&A is on the table
Bourla, M&A, Pfizer, United States, TNFRSF19 gene, Policy, tariffs
Merck & Co. breaks ground on $1B future US home of Keytruda
United States, Keytruda, Home environment, Merck, Wilmington, Biological Factors
Thermo Fisher jumps on the US investment bandwagon with $2B in additional spending
United States, Investments, Manufacture, Martes pennanti, Science, development aspects, Thermo Fisher